期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

溃疡性结肠炎患者外周血BPC和MPV的变化及意义

下载PDF
导出
摘要 检测56例活动期溃疡性结肠炎(UC)患者(实验组)及30例健康对照者(对照组)外周血血小板计数(BPC)和平均体积(MPV)。56例UC患者经用艾迪沙治疗后缓解37例(缓解组),同样方法检测其外周血中的BPC和MPV。结果缓解组、实验组BPC及MPV明显高于对照组(P<0.05,P<0.01),实验组明显高于缓解组(P<0.05);实验组不同程度UC患者BPC及MPV比较,P均<0.05。认为活动期UC患者外周血BPC及MPV明显升高,BPC及MPV可作为评价UC活动度及其严重程度的参考指标。
作者 张义元
机构地区 阳谷县人民医院
出处 《山东医药》 CAS 北大核心 2009年第2期93-94,共2页 Shandong Medical Journal
关键词 溃疡性结肠炎 血小板计数 血小板平均体积
分类号 R574.6 [医药卫生—消化系统]
  • 相关文献

参考文献9

  • 1Hayat M, Ariens RA, Moayycdi P, et al. Coagulation factor X Ⅲ and markers of thrombin gencration and fibrlnolysis in paticntswith inflammatory bowel disease [ J]. Eur J Gastroenterol Hepatol, 2002,14 ( 3 ) : 249-256.
  • 2Kjeldsen J,Lassen JF, Brandslund I, et al. Markers of coagulation and fibinolysis asmeasures of disease activity in inflammatory bowel disease[J]. Scand J Gastroenterol, 1998,33(6) :637-643.
  • 3欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华内科杂志,2001,40(2):138-141. 被引量：550
  • 4欧阳钦,Rakesh Tandon,KL Goh,潘国宗,KM Fock,Claudio Fiocchi,SK Lam,萧树东,张虎（翻译）,梁红亮（翻译）,王玉芳（翻译）,欧阳钦（审校）.亚太地区炎症性肠病处理共识意见(二)[J].胃肠病学,2006,11(5):301-305. 被引量：47
  • 5Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis [J]. Gastroenterology, 1998, 115 (1) : 182-205.
  • 6Van Bodegraven AA, Schoorl M, Baak JP, et al. Hemostatie imbalance in active and quiescent ulcerative colitis[ J]. Am J Gastroenterol, 2001, 96(4) : 487-493.
  • 7Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease [ J ]. Pathophysiol Haemost Thromb, 2002, 32 (2):92-96.
  • 8Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications [ J ]. Aliment Pharmacol Ther, 1997, 11 (3) :237-247.
  • 9黄庆科,黄智铭.炎症性肠病患者的vWF、血小板检测及其临床意义[J].胃肠病学和肝病学杂志,2003,12(3):282-283. 被引量：7

二级参考文献41

  • 1Stevens T R J,James J P, Sinnonds N J, et al. Circulating von Willebrand factro in inflammatory bowel disease. Gut, 1992,33(4):502-506.
  • 2Souto J C, Markinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci, 1995,40(9) : 1883-1889.
  • 3Halstensen T S, Mollnes T E, Brandtzaeg P. Persistent complement activation in submucosal bolld vessels of active inflammatory bowel disease : immunohistochemical evidence. Gastroenterology, 1989,97( 1 ) : 10-19.
  • 4Ahrenstedy O, Knutson L, Nilsson B, et al. Enhanced local production of complement components in the small intestines of patients with Crohn' s disease. N-Engl-J- Med, 1990,322(19) : 1345-1349.
  • 5Hattori R, Hamilton K, McEver R, et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J-Biol-Chem, 1989,264(15) :9053-9060.
  • 6Webberley M, Hart M, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut, 1993,34(2) :247-251.
  • 7Collins EC, Rampton DS. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut, 1995,36( 1 ) : 5-8.
  • 8Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume : a useful marker of inflammatory bowel disease activity. Am-J-Gastroenterol,2001,96(3) :776-781.
  • 9Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med, 1997, 337: 1029-1035.
  • 10Hanaucr SB, Feagan BG, Lichtenstein GR, Mayer LF,Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC,Olson A, Bao W, Rutgeerts P; ACCENT I Study Group.Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet, 2002, 359: 1541-1549.

共引文献598

山东医药
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部